Human Syndecan-1 / SDC1 / CD138 Protein (His Tag)

CD138,SDC,SYND1,syndecan,Syndecan-1

100ug (NPP4299) Please inquiry

Catalog Number	P11429-H08H
Organism Species	Human
Host	Human Cells
Synonyms	CD138,SDC,SYND1,syndecan,Syndecan-1
Molecular Weight	The recombinant human SDC1 consists of 245 amino acids and predictes a molecular mass of 25.6 kDa. In SDS-PAGE under reducing conditions, the apparent molecular mass of rh SDC1 is approximately 48-55 kDa due to glycosylation.
predicted N	Gln 18
SDS-PAGE
Purity	> 92 % as determined by SDS-PAGE
Protein Construction	A DNA sequence encoding the human SDC1 (NP_002988.3) extracellular domain (Met 1-Glu 251) was expressed, with a polyhistidine tag at the C-terminus.
Bio-activity
Research Area	Cancer \|Invasion microenvironment \|Adhesion molecule \|Extracelluar matrix \|proteoglycans
Formulation	Lyophilized from sterile PBS, pH 7.4 1. Normally 5 % - 8 % trehalose and mannitol are added as protectants before lyophilization. Specific concentrations are included in the hardcopy of COA.
Background	Syndecan-1 also known as SDC1 and CD138, is the most extensively studied member of the syndecan family. It is found mainly in epithelial cells, but its expression is developmentally regulated during embryonic development. Syndecan-1/SDC1/CD138 has been shown to mediate cell adhesion to several ECM molecules, and to act as a coreceptor for fibroblast growth factors, potent angiogenic growth factors involved also in differentiation. Syndecan-1/SDC1/CD138 expression is reduced during malignant transformation of various epithelia, and this loss correlates with the histological differentiation grade of squamous cell carcinomas, lacking from poorly differentiated tumours. In squamous cell carcinomas of the head and neck, positive syndecan-1 expression correlates with a more favourable prognosis. Experimental studies on the role of Syndecan-1 in malignant transformation have shown that Syndecan-1/SDC1/CD138 expression is associated with the maintenance of epithelial morphology, anchorage-dependent growth and inhibition of invasiveness in vitro.
Reference	Inki P, et al. (1996) The role of syndecan-1 in malignancies. Ann Med. 28(1): 63-7. Subramanian SV, et al. (1997) Regulated shedding of syndecan-1 and -4 ectodomains by thrombin and growth factor receptor activation. J Biol Chem. 272(23): 14713-20. Park PW, et al. (2001) Exploitation of syndecan-1 shedding by Pseudomonas aeruginosa enhances virulence. Nature. 411(6833): 98-102.